A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Clinical trial NCT04783389 · TERMINATED
Trial details
- NCT number
- NCT04783389
- Sponsor
- Connect Biopharm LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2022-04-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.